TORONTO--(BUSINESS WIRE)--Ontario, Canada is helping Novocol Pharmaceuticals of Canada Inc. expand and modernize its Cambridge facility, including converting an outdated production line into an R&D centre. The entire project will help the company diversify and develop new infection control products, increasing the global company’s competitiveness.
